Legend Biotech will hold a conference call on November 10, 2026, to discuss its third quarter financial results. The company's senior management will provide an overview of its quarterly performance and future outlook. Legend Biotech is a leading cell therapy company known for its CAR-T treatment CARVYKTI® for multiple myeloma, developed with Johnson & Johnson. Investors can access the live webcast and replay on the company’s website.
Legend Biotech's upcoming investor conference call is noted here with market context for health-sector stocks. For readers following health stocks, 77 of 150 US health-sector stocks on Pluang rose while 66 fell. Notable movers include AMWL at USD 14.20 (+4.87%), INO at USD 0.90 (+3.78%) with a buy order activity of 87%, and IQV at USD 283.00 (+3.55%). These figures are as of Oct 27, 2026 18:51 WIB.
The HVAC filters market is projected to grow from USD 4.66 billion in 2026 to USD 6.21 billion by 2031, at a CAGR of 5.9%. This growth is fueled by increasing awareness of indoor air quality, stricter regulations, and expanding infrastructure in cons...
In Q3 2026, vehicle sales remained steady but inventory levels increased by 9%, with a significant portion of both new and used vehicles aging on dealer lots. New vehicle inventory prices rose faster than sale prices, risking margin losses through ma...
Dr. Lidia Lae, psychologist and bestselling author, released Own Your Life Story Workbook to guide readers in examining how culture and personal narratives shape their identities and choices. The workbook offers practical exercises to help people ref...
Fast Simon introduced its Commerce-Native AI, a model designed for e-commerce that integrates merchandising, personalization, and optimization to increase revenue. This AI balances shopper intent, brand strategy, and business priorities, allowing mer...
Black Ore introduced Black Ore for Small Firms, an AI-powered tax automation platform designed for small to mid-sized accounting practices. It integrates with Intuit tax software, enabling firms to handle more clients without increasing staff by auto...
